K. Elgen

3.4k total citations · 2 hit papers
28 papers, 2.6k citations indexed

About

K. Elgen is a scholar working on Psychiatry and Mental health, Pharmacology and Experimental and Cognitive Psychology. According to data from OpenAlex, K. Elgen has authored 28 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Psychiatry and Mental health, 5 papers in Pharmacology and 5 papers in Experimental and Cognitive Psychology. Recurrent topics in K. Elgen's work include Schizophrenia research and treatment (9 papers), Electroconvulsive Therapy Studies (5 papers) and Epilepsy research and treatment (5 papers). K. Elgen is often cited by papers focused on Schizophrenia research and treatment (9 papers), Electroconvulsive Therapy Studies (5 papers) and Epilepsy research and treatment (5 papers). K. Elgen collaborates with scholars based in Denmark, Norway and Sweden. K. Elgen's co-authors include U. G. Ahlfors, S. J. Dencker, Per Bech, Ole Christian Lingjærde, Reidulv Hatlevoll, K. Nygaard, Steinar Hagen, Anders Jakobsen, M Mäntylä and Johan Tausjø and has published in prestigious journals such as Cancer, Acta Psychiatrica Scandinavica and Radiotherapy and Oncology.

In The Last Decade

K. Elgen

27 papers receiving 2.5k citations

Hit Papers

The UKU side effect rating scale: A new comprehensive rat... 1987 2026 2000 2013 1987 1992 400 800 1.2k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. The UKU side effect rating scale: A new comprehensive rating scale for psychotropic drugs and a cross‐sectional study of side effects in neuroleptic‐treated patients
    1987 1.4k citations U. G. Ahlfors, Per Bech et al. Acta Psychiatrica Scandinavica profile →
  2. Pre‐operative radiotherapy prolongs survival in operable esophageal carcinoma: A randomized, multicenter study of pre‐operative radiotherapy and chemotherapy. The second scandinavian trial in esophageal cancer
    1992 473 citations K. Nygaard, Steinar Hagen et al. World Journal of Surgery profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
K. Elgen Denmark 9 1.3k 717 582 497 323 28 2.6k
Richard C. Risser United States 31 2.6k 2.1× 285 0.4× 173 0.3× 676 1.4× 321 1.0× 48 4.2k
Walter Gianni Italy 31 630 0.5× 454 0.6× 271 0.5× 130 0.3× 117 0.4× 78 3.1k
Leorey N. Saligan United States 27 716 0.6× 636 0.9× 69 0.1× 258 0.5× 267 0.8× 150 2.9k
Doug Hayden United States 22 1.1k 0.9× 119 0.2× 149 0.3× 287 0.6× 201 0.6× 25 2.7k
Anzalee Khan United States 33 1.1k 0.8× 117 0.2× 426 0.7× 101 0.2× 319 1.0× 186 3.0k
Riccardo Torta Italy 24 559 0.4× 271 0.4× 38 0.1× 270 0.5× 207 0.6× 74 1.7k
Julio Pascual Spain 45 6.2k 4.9× 209 0.3× 885 1.5× 266 0.5× 142 0.4× 280 8.2k
Akira Kugaya Japan 26 425 0.3× 380 0.5× 78 0.1× 260 0.5× 207 0.6× 45 2.6k
Paul M. Copeland United States 25 1.2k 0.9× 74 0.1× 503 0.9× 191 0.4× 388 1.2× 51 2.7k
Gwen L. Zornberg United States 15 692 0.6× 60 0.1× 69 0.1× 404 0.8× 238 0.7× 23 1.9k

Countries citing papers authored by K. Elgen

Since Specialization
Citations

This map shows the geographic impact of K. Elgen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K. Elgen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K. Elgen more than expected).

Fields of papers citing papers by K. Elgen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by K. Elgen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K. Elgen. The network helps show where K. Elgen may publish in the future.

Co-authorship network of co-authors of K. Elgen

This figure shows the co-authorship network connecting the top 25 collaborators of K. Elgen. A scholar is included among the top collaborators of K. Elgen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with K. Elgen. K. Elgen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Wistedt, Börje, et al.. (1995). Treatment of acutely disturbed psychotic patients: assessment of a new treatment strategy. Nordic Journal of Psychiatry. 49(sup35). 63–77. 5 indexed citations
3.
Nygaard, Harald A., et al.. (1994). Dosing of neuroleptics in elderly demented patients with aggressive and agitated behaviour: A double-blind study with zuclopenthixol. Current Medical Research and Opinion. 13(4). 222–232. 8 indexed citations
4.
Bech, Per, Ulrik Fredrik Malt, S. J. Dencker, et al.. (1993). Preface. Acta Psychiatrica Scandinavica. 87(S372). 3–3. 125 indexed citations
5.
Nygaard, Harald A., et al.. (1992). Zuclopenthixol, melperone and haloperidol/levomepromazine in the elderly. Meta-analysis of two double-blind trials at 15 nursing homes in Norway. Current Medical Research and Opinion. 12(10). 615–622. 5 indexed citations
6.
Elgen, K., et al.. (1992). Zuclopenthixol and thioridazine in the treatment of aggressive, elderly patients: A double‐blind, controlled, multicentre study. International Journal of Geriatric Psychiatry. 7(5). 369–375. 6 indexed citations
7.
Hatlevoll, Reidulv, Steinar Hagen, Hanne Sand Hansen, et al.. (1992). Bleomycin/cis-platin as neoadjuvant chemotherapy before radical radiotherapy in localized, inoperable carcinoma of the esophagus. Radiotherapy and Oncology. 24(2). 114–116. 35 indexed citations
8.
Nygaard, K., Steinar Hagen, Hanne Sand Hansen, et al.. (1992). Pre‐operative radiotherapy prolongs survival in operable esophageal carcinoma: A randomized, multicenter study of pre‐operative radiotherapy and chemotherapy. The second scandinavian trial in esophageal cancer. World Journal of Surgery. 16(6). 1104–1109. 473 indexed citations breakdown →
9.
Elgen, K., Carl‐Gerhard Gottfries, & Anna Lena Nyth. (1991). Effekt av citalopram på emosjonelle forstyrrelser hos pasienter med Alzheimer demens. Nordisk Psykiatrisk Tidsskrift. 45(sup23). 23–27. 2 indexed citations
10.
Jensen, Dorte Møller, et al.. (1989). Zuclopenthixol and haloperidol/levomepromazine in the treatment of elderly patients with symptoms of aggressiveness and agitation: a double-blind, multi-centre study.. PubMed. 5(5). 285–91. 7 indexed citations
11.
Nygaard, Harald A., et al.. (1988). Zuclopenthixol and melperon in the treatment of elderly patients: a double-blind, controlled, multi-centre study.. PubMed. 5(3). 152–8. 4 indexed citations
12.
Bakke, Kristin M., et al.. (1987). [Cisordinol and Buronil in the elderly. A controlled multi-center double-blind comparison].. PubMed. 107(9). 827–9. 2 indexed citations
13.
Bech, Per, U. G. Ahlfors, Sven J. Dencker, K. Elgen, & Odd Lingjærde. (1986). UKU's Bivirkningsskala Skala Til Registering af Uønskede Virkninger af Psykofarmaka. Nordisk Psykiatrisk Tidsskrift. 40(2). 147–157. 5 indexed citations
14.
Dencker, S. J., et al.. (1986). Classification of Side Effects in Psychopharmacology. Pharmacopsychiatry. 19(1). 40–42. 5 indexed citations
15.
Andersen, A. P., P Berdal, F. Edsmyr, et al.. (1984). Irradiation, chemotherapy and surgery in esophageal cancer: A randomized clinical study. Radiotherapy and Oncology. 2(3). 179–188. 44 indexed citations
16.
Lærum, E, et al.. (1983). [Psychosomatic disorders in general practice. Recording of symptoms, syndromes, personality of patients, social conditions, consequences and treatment of the disorders].. PubMed. 103(8-9). 783–8, 99. 1 indexed citations
17.
Elgen, K., et al.. (1981). Cis(Z)-clopenthixol. The neuroleptically active isomer of clopenthixol. A presentation of five double-blind clinical investigations and other studies with cis(Z)-clopenthixol (Cisordinol, Clopixol).. PubMed. 294. 5–12. 8 indexed citations
18.
19.
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Richard C. Risser Breakdown of academic impact, for papers by Walter Gianni Breakdown of academic impact, for papers by Leorey N. Saligan Breakdown of academic impact, for papers by Doug Hayden Breakdown of academic impact, for papers by Anzalee Khan Breakdown of academic impact, for papers by Riccardo Torta Breakdown of academic impact, for papers by Julio Pascual Breakdown of academic impact, for papers by Akira Kugaya Breakdown of academic impact, for papers by Paul M. Copeland Breakdown of academic impact, for papers by Gwen L. Zornberg
Rankless by CCL
2026